These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9218619)
1. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. Fischer MB; Prodeus AP; Nicholson-Weller A; Ma M; Murrow J; Reid RR; Warren HB; Lage AL; Moore FD; Rosen FS; Carroll MC J Immunol; 1997 Jul; 159(2):976-82. PubMed ID: 9218619 [TBL] [Abstract][Full Text] [Related]
2. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367 [TBL] [Abstract][Full Text] [Related]
3. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice. Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230 [TBL] [Abstract][Full Text] [Related]
4. Complement activation in septic shock due to gram-negative and gram-positive bacteria. León C; Rodrigo MJ; Tomasa A; Gallart MT; Latorre FJ; Rius J; Brugués J Crit Care Med; 1982 May; 10(5):308-10. PubMed ID: 6918253 [TBL] [Abstract][Full Text] [Related]
8. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436 [TBL] [Abstract][Full Text] [Related]
9. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213 [TBL] [Abstract][Full Text] [Related]
10. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006 [TBL] [Abstract][Full Text] [Related]
11. Role of complement in Mycobacterium avium pathogenesis: in vivo and in vitro analyses of the host response to infection in the absence of complement component C3. Bohlson SS; Strasser JA; Bower JJ; Schorey JS Infect Immun; 2001 Dec; 69(12):7729-35. PubMed ID: 11705954 [TBL] [Abstract][Full Text] [Related]
12. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Caliezi C; Wuillemin WA; Zeerleder S; Redondo M; Eisele B; Hack CE Pharmacol Rev; 2000 Mar; 52(1):91-112. PubMed ID: 10699156 [TBL] [Abstract][Full Text] [Related]
13. Complement activation and group B streptococcal infection in the newborn: similarities to endotoxin shock. Fenton LJ; Strunk RC Pediatrics; 1977 Dec; 60(6):901-7. PubMed ID: 341069 [TBL] [Abstract][Full Text] [Related]
14. Influence of C1-inhibitor on inflammation, edema and shock. Dickneite G Behring Inst Mitt; 1993 Dec; (93):299-305. PubMed ID: 8172580 [TBL] [Abstract][Full Text] [Related]
15. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates. Doekes G; van Es LA; Daha MR Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866 [TBL] [Abstract][Full Text] [Related]
16. The role of C1, C1-inactivator and C4 in modulating immune precipitation. Schifferli JA; Steiger G; Schapira M Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288 [TBL] [Abstract][Full Text] [Related]
17. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Hack CE; Ogilvie AC; Eisele B; Eerenberg AJ; Wagstaff J; Thijs LG Intensive Care Med; 1993; 19 Suppl 1():S19-28. PubMed ID: 8053997 [TBL] [Abstract][Full Text] [Related]
18. A postulated mechanism for heparin's potentiation of C1 inhibitor function. Caughman GB; Boackle RJ; Vesely J Mol Immunol; 1982 Feb; 19(2):287-95. PubMed ID: 7099168 [TBL] [Abstract][Full Text] [Related]
19. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. Reid RR; Prodeus AP; Khan W; Hsu T; Rosen FS; Carroll MC J Immunol; 1997 Jul; 159(2):970-5. PubMed ID: 9218618 [TBL] [Abstract][Full Text] [Related]
20. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Wessels MR; Butko P; Ma M; Warren HB; Lage AL; Carroll MC Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11490-4. PubMed ID: 8524789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]